Lixte Biotechnology Holdings Inc
NASDAQ:NMAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lixte Biotechnology Holdings Inc
NASDAQ:NMAD
|
US |
|
S
|
Soho China Ltd
F:45S
|
CN |
|
K
|
Kalnorth Gold Mines Ltd
F:OBF
|
AU |
Intrinsic Value
The intrinsic value for
Lixte Biotechnology Holdings Inc (NMAD) under the Base Case is 0.67 USD.
Compared with the current market price of 4.05 USD, the stock appears
Overvalued by 83% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Lixte Biotechnology Holdings Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Lixte Biotechnology Holdings Inc
Earnings Waterfall
Lixte Biotechnology Holdings Inc
The intrinsic value for
Lixte Biotechnology Holdings Inc (NMAD) under the Base Case is 0.67 USD.
Compared with the current market price of 4.05 USD, the stock appears Overvalued by 83% .